NACHWEIS VON BETA-HÄMOLYTISCHEN PATHOGENEN

Patent europeic · EP3420099 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3420099
Numer da la dumonda
EP17756931
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
23-02-2017
Publitgà
02-01-2019
Concedì
07-04-2021
Stritgà
04-10-2022
Motiv
Taxa annuala betg pajada
Classas IPC
C12Q 1/04 (2006.01)
Prioritad
US 201662300372 P 26.02.2016
Dumonda PCT
PCT/SG2017/050081 23.02.2017
Publicaziun PCT
WO2017/146648 31.08.2017
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 04-10-2022

    Stritgà, taxa betg pajada

    Published in Swissreg on 04.10.2022

  2. 16-02-2022

    Midada

    Published in Swissreg on 16.02.2022

  3. 07-04-2021

    Concedì

    Published in Swissreg on 07.04.2021

Partidas

Possessur

Temasek Life Sciences Laboratory Limited

1 Research Link National University of Singapore, Singapore 117604, SG

Inventur

SUM, Rongji

Singapore 117604, SG

SWAMINATHAN, Muthukaruppan

Singapore 117604, SG

CHEONG, Ian

Singapore 117604, SG

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.